25 related articles for article (PubMed ID: 31570427)
1. Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model.
Kim S; Lee JY; Park EJ; Ahn YD; Cheon Y; Sim W; Lee HJ
Eur Radiol Exp; 2024 Mar; 8(1):39. PubMed ID: 38503996
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive Fluorescence Imaging of Breast Cancer Metastasis to the Brain in an Orthotopic Nude-mouse Model With Very-narrow-band-width Laser Excitation of Red Fluorescent Protein Resulting in an Ultra-bright Signal Without Skin Autofluorescence.
Kubota Y; Aoki Y; Wang A; Chang N; Tarantino S; Gallagher S; Tsunoda T; Hoffman RM
In Vivo; 2024; 38(1):69-72. PubMed ID: 38148053
[TBL] [Abstract][Full Text] [Related]
3. Precise Non-invasive Imaging Mouse Model of Pancreatic Cancer: Very Narrow Band-width Laser Fluorescence Excitation of Green Fluorescent Protein Provides Ultra-bright Tumor Images With no Skin Autofluorescence.
Kubota Y; Wang A; Chang N; Tarantino S; Gallagher S; Aoki Y; Masaki N; Obara K; Morinaga S; Tsunoda T; Hoffman RM
Cancer Diagn Progn; 2024; 4(1):30-33. PubMed ID: 38173656
[TBL] [Abstract][Full Text] [Related]
4. Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613.
Lee KC; Maturo C; Perera CN; Luddy J; Rodriguez R; Shorr R
Ann Transl Med; 2014 Sep; 2(9):91. PubMed ID: 25405166
[TBL] [Abstract][Full Text] [Related]
5. Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model.
Yang M; Baranov E; Wang JW; Jiang P; Wang X; Sun FX; Bouvet M; Moossa AR; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3824-9. PubMed ID: 11891294
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic metastasis of primary kidney cancer: A presentation of a serie of clinical cases and revision of the literature.].
Gutiérrez Zurimendi G; Llarena Ibarguren R; Lecumberri Castaños D; Fernández Pereda R; Urresola Olabarrieta A; García De Casasola-Rodríguez G; Zabala Egurrola JA; Arruza-Echevarría A
Arch Esp Urol; 2020 Mar; 73(2):147-154. PubMed ID: 32124846
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine Combination Nano Therapies for Pancreatic Cancer.
Samanta K; Setua S; Kumari S; Jaggi M; Yallapu MM; Chauhan SC
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31689930
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer.
Sarvepalli D; Rashid MU; Rahman AU; Ullah W; Hussain I; Hasan B; Jehanzeb S; Khan AK; Jain AG; Khetpal N; Ahmad S
Crit Rev Oncog; 2019; 24(2):199-212. PubMed ID: 31679214
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment.
Kong X; Feng M; Wu L; He Y; Mao H; Gu Z
Drug Deliv; 2022 Dec; 29(1):1595-1607. PubMed ID: 35612309
[TBL] [Abstract][Full Text] [Related]
10. Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.
Nishino H; Hollandsworth HM; Sugisawa N; Yamamoto J; Tashiro Y; Inubushi S; Hamada K; Sun YU; Lim H; Amirfakhri S; Filemoni F; Hoffman RM; Bouvet M
In Vivo; 2020; 34(6):3153-3157. PubMed ID: 33144418
[TBL] [Abstract][Full Text] [Related]
11. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
[TBL] [Abstract][Full Text] [Related]
12. VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
Shi Y; Tong M; Wu Y; Yang Z; Hoffman RM; Zhang Y; Tian Y; Qi M; Lin Y; Liu Y; Dai L; Sun Y; Wang Z
Anticancer Res; 2013 Feb; 33(2):409-17. PubMed ID: 23393331
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
[TBL] [Abstract][Full Text] [Related]
14. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Lwin TM; Higuchi T; Kiyuna T; Miyake M; Oshiro H; Bouvet M; Unno M; Hoffman RM
Cell Cycle; 2018; 17(7):868-873. PubMed ID: 29623758
[TBL] [Abstract][Full Text] [Related]
15. Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Zhang Z; Park JH; Kawaguchi K; Chawla SP; Bouvet M; Singh SR; Unno M; Hoffman RM
Anticancer Res; 2019 Oct; 39(10):5339-5344. PubMed ID: 31570427
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.
Lee NC; Bouvet M; Nardin S; Jiang P; Baranov E; Rashidi B; Yang M; Wang X; Moossa AR; Hoffma RM
Clin Exp Metastasis; 2000; 18(5):379-84. PubMed ID: 11467769
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
